NCT00001422View on ClinicalTrials.gov

A Controlled Trial of Intermittent Fludarabine for Psoriatic Arthritis

PHASE2CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

June 30, 1995

Study Completion Date

April 30, 2000

Conditions

Arthritis, PsoriaticPsoriasis

Interventions

DRUG

fludarabine

Trial Locations (1)

20892

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Bethesda

All Listed Sponsors

lead

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

NIH